WallStreetZenWallStreetZen

NYSEMKT: ELMD
Electromed Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Electromed earnings were $7.5M for the trailing 12 months ending Jun 30, 2025, with 48.3% growth year over year. The latest ELMD earnings report on Jun 30, 2025 announced Q2 2025 earnings of $2.2M, up 16.6% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, ELMD reported annual earnings of $7.5M, with 46.3% growth. The next ELMD earnings date is Nov 11, 2025.

ELMD past earnings growth

How has ELMD's earnings growth performed historically?

Company
48.33%
Industry
83.98%
Market
34.43%
ELMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ELMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ELMD's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ELMD earnings history

Current Revenue
$64.0M
Current Earnings
$7.5M
Current Profit Margin
11.8%
ELMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ELMD Return on Equity

Current Company
17.5%
Current Industry
15.2%
Current Market
30.7%
ELMD's Return on Equity (17.5%)... subscribe to Premium to read more.
High Return on Equity Performance

ELMD undefined

Current Company
14.5%
Current Industry
8.9%
ELMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ELMD announces earnings.

ELMD undefined

Current Company
23.73%
Current Industry
10.6%
ELMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ELMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ELMD$11.32M$7.54M+12.22%$0.89
STEX-$25.31M-$26.25MN/A-$1.03
MASS-$13.40M-$18.44MN/A-$0.54
CVRX-$46.15M-$52.25MN/A-$2.07
CVN/AN/AN/AN/A
View Top Medical Device Stocks

ELMD earnings dates

Next earnings date
Nov 11, 2025

Electromed Earnings Reports & History FAQ

What were Electromed's earnings last quarter?

On ELMD's earnings call on Invalid Date, Electromed (NYSEMKT: ELMD) reported Q2 2025 earnings per share (EPS) of $0.26, up 23.81% year over year. Total ELMD earnings for the quarter were $2.20 million. In the same quarter last year, Electromed's earnings per share (EPS) was $0.21.

If you're new to stock investing, here's how to buy Electromed stock.

When does Electromed report earnings?

The next ELMD earnings date is Invalid Date. Add ELMD to your watchlist to be reminded of Electromed's next earnings date.

Is Electromed profitable or losing money?

As of the last Electromed earnings report, Electromed is currently profitable. Electromed's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $7.54 million, a 46.35% increase year over year.

What was ELMD's earnings growth in the past year?

As of Electromed's earnings date in Invalid Date, Electromed's earnings has grown 48.33% year over year. This is 35.65 percentage points lower than the US Medical Devices industry earnings growth rate of 83.98%. ELMD earnings in the past year totalled $7.54 million.

What are Electromed's earnings expectations?

The current EPS estimate for Electromed's earnings report in Invalid Date is $0.21.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.